Motivi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -23.55%
(FY 2019)
- Profit -14.12%
(FY 2019)
- Ebitda -65.13%
(FY 2019)
- Net Worth 9.57%
(FY 2019)
- Total Assets 20.59%
(FY 2019)
About Motivi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Oscar Dsouza and Vikram Naharwar serve as directors at the Company.
- CIN/LLPIN
U51909GA2014PTC007454
- Company No.
007454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
North Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Motivi Pharmaceuticals Private Limited offer?
Motivi Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Heart Care, Hair Care, Shampoo, Kidney Care, Skin Care, Bath Essentials, Stomach Care, Women Care, Women Care Supplements.
Who are the key members and board of directors at Motivi Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Naharwar  | Director | 25-Mar-2014 | Current |
| Oscar Dsouza | Director | 16-Sep-2014 | Current |
Financial Performance and Corporate Structure Insights of Motivi Pharmaceuticals.
Motivi Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 23.55% decrease. The company also saw a substantial fall in profitability, with a 14.12% decrease in profit. The company's net worth moved up by a moderate rise of 9.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Motivi Pharmaceuticals?
In 2019, Motivi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Motivi Pharmaceuticals?
Unlock and access historical data on people associated with Motivi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Motivi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Motivi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
